Article info
Unexpected outcome (positive or negative) including adverse drug reactions
CASE REPORT
Bivalirudin fails to prevent atrial thrombus development in heparin-induced thrombocytopaenia and thrombosis syndrome
- Correspondence to Dr. Thomas Breen, thomasbreen01{at}gmail.com
Citation
Bivalirudin fails to prevent atrial thrombus development in heparin-induced thrombocytopaenia and thrombosis syndrome
Publication history
- Accepted September 20, 2018
- First published October 14, 2018.
Online issue publication
October 20, 2018
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ.